Drug
Bms 833923
Bms 833923: highest development phase Phase 1, developed by Bristol-Myers Squibb. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMS-833923 (XL139) NCT00670189 | Phase 1 | Hedgehog Pathway |
| BMS-833923 NCT00884546 | Phase 1 | Advanced Cancer, Various, NOS |
Latest
No recent events.
Follow Bms 833923 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.